Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
Open in App
IND
USA
IND
IND
×
Close
IND
USA
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(4)
About
Alembic Pharmaceuticals Ltd.
NSE: APLLTD
|
BSE: 533573
|
ISIN: INE901L01018
|
Industry: Pharmaceuticals
52 week high
|
Strong Performer, Getting Expensive
1030.1500
-17.10
(
-1.63
%)
NSE
Nov 13, 2026
15:31 PM
New 52W High today
Volume:
422.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alembic Pharmaceuticals Ltd.
12 Feb 2025
52 week high
1030.15
-1.63%
Alembic Pharma (BUY): Earnings recovery on normalised Azithromycin base
Buy:
Alembic Pharmaceuticals Ltd.
by
BOB Capital Markets Ltd.
Target: 1032
Target
BOB Capital Markets Ltd.
US and ROW sales grew above our estimates of 5% and 13% respectively, reporting growth of 10% each
Alembic Pharma has gained
23.93%
in the last 3 Months
More from Alembic Pharmaceuticals Ltd.
Recommended
Pre Monday: New opportunities as markets rise, and some tears
The Baseline |
14 Nov 2026, 12:00PM
Not all revenue beats are equal: inside Q2’s biggest surprises
The Baseline |
13 Nov 2026
Earnings Call Transcript - Q1FY21 for Alembic Pharmaceuticals
|
22 Jul 2020